Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Explainable AI is almost as sharp as human experts when the cause is simple and straightforward, as with ingestion of a single common cleaning product.
JPMorgan Chase is forging a new path in the healthcare space following the downfall of Haven Healthcare, its recent joint venture with Amazon and Berkshire Hathaway.
AMN Healthcare, a medical staffing firm based in Texas, has acquired a virtual care company that specializes in home health and outpatient care for $42 million.
Natural language processing of social media posts is useful for identifying depression, anxiety and suicidal thinking, but models trained on population data cannot discern long-term patterns in any one person’s state of mind.
AI is poised to help settle an argument that’s been roiling academic psychiatry for more than a century: Are bipolar disorder and schizophrenia two distinct diagnoses—or points along a single continuum?
Researchers at Duke University are working on a vaccine that has the potential to stop future pandemics by protecting against a variety of coronavirus infections that can jump from animals to humans.
